清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Development in PaCO2 over 12 months in patients with COPD with persistent hypercapnic respiratory failure treated with high-flow nasal cannula—post-hoc analysis from a randomised controlled trial

作者
Line Hust Storgaard,Hans Hockey,Ulla Møller Weinreich
出处
期刊:BMJ Open Respiratory Research [BMJ]
卷期号:7 (1): e000712-e000712 被引量:14
标识
DOI:10.1136/bmjresp-2020-000712
摘要

Introduction Persistent hypercapnic failure in chronic obstructive pulmonary disease (COPD) is associated with poor prognosis. Long-term home non-invasive ventilation is recommended for patients with PaCO2 >7.0 kPa. Domiciliary high-flow nasal cannula (HFNC) reduces PaCO2 in short-term studies. This post-hoc analysis examines the effect of HFNC on PaCO2 levels, exacerbations and admissions in patients with COPD with persistent hypercapnic and hypoxic failures. Methods The original trial included 74 long-term oxygen-treated patients (31 HFNC treated/43 controls) with persistent hypercapnic failure (PaCO2 >6 kPa) who completed the 12-month study period. Baseline data included age, sex, blood gases, exacerbations and hospital admissions in the previous year. Data on blood gases were also recorded at 6 and 12 months for all patients. In addition, acute changes in blood gases after 30 min of HFNC use at site visits were examined, as were exacerbations and hospital admissions during study. Results Patients were comparable at baseline. After 12 months there was a 1.3% decrease in PaCO2 in patients using HFNC and a 7% increase in controls before HFNC use on site (p=0.003). After 30 min of HFNC at visits PaCO2 changed significantly, with comparable reductions, at 0, 6 and 12 months, including for controls who tried HFNC at study end (p<0.001). The exacerbation rate increased, compared with 12 months prestudy, by 2.2/year for controls (p<0.001) and 0.15/year for HFNC-treated patients (p=0.661). Hospital admission rates increased in the control group,+0.3/year from prestudy (p=0.180), And decreased by 0.67/year (p=0.013)for HFNC-treated patients. Conclusion This post-hoc analysis indicates that HFNC stabilises patients with COPD with persistent hypoxic and hypercapnic failures, in terms of PaCO2, exacerbations and number of hospitalisations, whereas those not receiving HFNC worsened. This suggests that HFNC is a possible treatment for patients with persistent hypercapnic COPD.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
doudou完成签到,获得积分10
16秒前
落后的山槐完成签到,获得积分10
34秒前
59秒前
LY发布了新的文献求助10
1分钟前
活力尔柳完成签到 ,获得积分10
1分钟前
lilylwy完成签到 ,获得积分0
1分钟前
朝朝的应助被萧雨墨采纳,获得10
1分钟前
单纯的天抒完成签到,获得积分10
1分钟前
Maestro_S的应助被科研通管家采纳,获得10
1分钟前
1分钟前
LY完成签到,获得积分10
1分钟前
彩色听筠完成签到,获得积分10
2分钟前
文静的丹彤完成签到,获得积分10
2分钟前
勤劳觅山完成签到,获得积分10
2分钟前
专注寒蕾完成签到,获得积分10
3分钟前
分手吧亚索完成签到 ,获得积分10
3分钟前
无极微光的应助被科研通管家采纳,获得20
3分钟前
3分钟前
3分钟前
3分钟前
urah完成签到,获得积分10
3分钟前
万能图书馆的应助被urah采纳,获得10
3分钟前
yuanmeng434完成签到 ,获得积分10
3分钟前
lily完成签到 ,获得积分10
3分钟前
神勇寄风完成签到,获得积分10
4分钟前
李祺完成签到 ,获得积分10
4分钟前
落寞的姿完成签到,获得积分10
4分钟前
火柴盒完成签到,获得积分10
4分钟前
漂亮的乐曲完成签到,获得积分10
5分钟前
Maestro_S的应助被科研通管家采纳,获得10
5分钟前
5分钟前
5分钟前
5分钟前
urah发布了新的文献求助10
5分钟前
愤怒的微笑完成签到,获得积分10
5分钟前
宣灵薇完成签到 ,获得积分0
5分钟前
浮华乱世完成签到 ,获得积分10
5分钟前
风趣的莫英完成签到,获得积分10
6分钟前
沉默怡完成签到,获得积分10
6分钟前
Bonnie完成签到 ,获得积分10
6分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190226
求助须知:如何正确求助?哪些是违规求助? 9577355
关于积分的说明 21852358
捐赠科研通 7788741
什么是DOI,文献DOI怎么找? 3436310
关于科研通互助平台的介绍 2560106
邀请新用户注册赠送积分活动 2482902